| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 147, 1228-1237, Copyright © 1995 by American Society for Investigative Pathology
REGULAR ARTICLES |
MH Barcellos-Hoff, EJ Ehrhart, M Kalia, R Jirtle, K Flanders and ML Tsang
Life Sciences Division, Lawrence Berkely Laboratory, University of California, Berkeley 94720, USA.
The biological activity of transforming growth factor-beta 1 (TGF-beta) is governed by dissociation from its latent complex. Immunohistochemical discrimination of active and latent TGF-beta could provide insight into TGF-beta activation in physiological and pathological processes. However, evaluation of immunoreactivity specificity in situ has been hindered by the lack of tissue in which TGF-beta status is known. To provide in situ analysis of antibodies to differentiate between these functional forms, we used xenografts of human tumor cells modified by transfection to overexpress latent TGF- beta or constitutively active TGF-beta. This comparison revealed that, whereas most antibodies did not differentiate between TGF-beta activation status, the immunoreactivity of some antibodies was activation dependent. Two widely used peptide antibodies to the amino- terminus of TGF-beta, LC(1-30) and CC(1-30) showed marked preferential immunoreactivity with active TGF-beta versus latent TGF-beta in cryosections. However, in formalin-fixed, paraffin-embedded tissue, discrimination of active TGF-beta by CC(1-30) was lost and immunoreactivity was distinctly extracellular, as previously reported for this antibody. Similar processing-dependent extracellular localization was found with a neutralizing antibody raised to recombinant TGF-beta. Antigen retrieval recovered cell-associated immunoreactivity of both antibodies. Two antibodies to peptides 78-109 showed mild to moderate preferential immunoreactivity with active TGF- beta only in paraffin sections. LC(1-30) was the only antibody tested that discriminated active from latent TGF-beta in both frozen and paraffin-embedded tissue. Thus, in situ discrimination of active versus latent TGF-beta depends on both the antibody and tissue preparation. We propose that tissues engineered to express a specific form of a given protein provide a physiological setting in which to evaluate antibody reactivity with specific functional forms of a protein.
This article has been cited by other articles:
 |
|
 |
|
  S. Belmadani, J. Bernal, C.-C. Wei, M. A. Pallero, L. Dell'Italia, J. E. Murphy-Ullrich, and K. H. Berecek A Thrombospondin-1 Antagonist of Transforming Growth Factor-{beta} Activation Blocks Cardiomyopathy in Rats with Diabetes and Elevated Angiotensin II Am. J. Pathol., September 1, 2007; 171(3): 777 - 789. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Chua, S. E. Dunsmore, P. H. Clingen, S. E. Mutsaers, S. D. Shapiro, A. W. Segal, J. Roes, and G. J. Laurent Mice Lacking Neutrophil Elastase Are Resistant to Bleomycin-Induced Pulmonary Fibrosis Am. J. Pathol., January 1, 2007; 170(1): 65 - 74. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Hahm, M. E. Lukashev, Y. Luo, W. J. Yang, B. M. Dolinski, P. H. Weinreb, K. J. Simon, L. Chun Wang, D. R. Leone, R. R. Lobb, et al. {alpha}v{beta}6 Integrin Regulates Renal Fibrosis and Inflammation in Alport Mouse Am. J. Pathol., January 1, 2007; 170(1): 110 - 125. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Debacq-Chainiaux, C. Borlon, T. Pascal, V. Royer, F. Eliaers, N. Ninane, G. Carrard, B. Friguet, F. de Longueville, S. Boffe, et al. Repeated exposure of human skin fibroblasts to UVB at subcytotoxic level triggers premature senescence through the TGF-{beta}1 signaling pathway J. Cell Sci., February 15, 2005; 118(4): 743 - 758. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L.-J. Ma, H. Yang, A. Gaspert, G. Carlesso, M. M. Barty, J. M. Davidson, D. Sheppard, and A. B. Fogo Transforming Growth Factor-{beta}-Dependent and -Independent Pathways of Induction of Tubulointerstitial Fibrosis in {beta}6-/- Mice Am. J. Pathol., October 1, 2003; 163(4): 1261 - 1273. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Takeda, M. Spatz, C. Ruetzler, R. McCarron, K. Becker, J. Hallenbeck, N. Feuerstein, S. Goldman, and G. Feuerstein Induction of Mucosal Tolerance to E-Selectin Prevents Ischemic and Hemorrhagic Stroke in Spontaneously Hypertensive Genetically Stroke-Prone Rats * Editorial Comment Stroke, September 1, 2002; 33(9): 2156 - 2164. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. B. Ewan, G. Shyamala, S. A. Ravani, Y. Tang, R. Akhurst, L. Wakefield, and M. H. Barcellos-Hoff Latent Transforming Growth Factor-{beta} Activation in Mammary Gland : Regulation by Ovarian Hormones Affects Ductal and Alveolar Proliferation Am. J. Pathol., June 1, 2002; 160(6): 2081 - 2093. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Braley-Mullen, K. Chen, Y. Wei, and S. Yu Role of TGF{beta} in Development of Spontaneous Autoimmune Thyroiditis in NOD.H-2h4 Mice J. Immunol., December 15, 2001; 167(12): 7111 - 7118. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Y. Chang, L. Birch, C. Woodham, L. I. Gold, and G. S. Prins Neonatal Estrogen Exposure Alters the Transforming Growth Factor-{beta} Signaling System in the Developing Rat Prostate and Blocks the Transient p21cip1/waf1 Expression Associated with Epithelial Differentiation Endocrinology, June 1, 1999; 140(6): 2801 - 2813. [Abstract] [Full Text]
|
|
|
|
|
|
J. Wang, H. Zheng, C.-C. Sung, K. K. Richter, and M. Hauer-Jensen Cellular Sources of Transforming Growth Factor-ß Isoforms in Early and Chronic Radiation Enteropathy Am. J. Pathol., November 1, 1998; 153(5): 1531 - 1540. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Zaher, P. M. Fernandez-Salguero, J. Letterio, M. S. Sheikh, A. J. Fornace Jr., A. B. Roberts, and F. J. Gonzalez The Involvement of Aryl Hydrocarbon Receptor in the Activation of Transforming Growth Factor-beta and Apoptosis Mol. Pharmacol., August 1, 1998; 54(2): 313 - 321. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. H. Schulick, A. J. Taylor, W. Zuo, C.-b. Qiu, G. Dong, R. N. Woodward, R. Agah, A. B. Roberts, R. Virmani, and D. A. Dichek Overexpression of transforming growth factor beta 1 in arterial endothelium causes hyperplasia, apoptosis, and cartilaginous metaplasia PNAS, June 9, 1998; 95(12): 6983 - 6988. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
